JIMMY LAFAILLE: Open Payments
NPI 1811251911 · BOYNTON BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$410 in 18 payments from 7 companies in 2025. Trend: 2023 $369 · 2024 $735 · 2025 $410
Food & beverage: $410
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 6 | $125 |
| Novo Nordisk Inc | 3 | $86 |
| Almatica Pharma LLC | 3 | $63 |
| Vanda Pharmaceuticals Inc. | 2 | $60 |
| ABBVIE INC. | 2 | $37 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
Products named: LYBALVI, LOREEV XR, FANAPT, Wegovy, VRAYLAR, VIVITROL, CAPLYTA, ARISTADA.
Industry payments across FL — which companies pay providers there.
